Under the leadership and concern of the Pudong New District Party Committee and the district government, Zhangjiang Hi-Tech Park hosted the 2010 Shanghai World Expo Theme Pavilion and the City Future Pavilion
On March 3, 2010, Dr. Claus Kremoser, Chief Executive Officer of Phenex Pharmaceuticals AG, Germany, and Mr. Thomas Hoffmann, Chief Financial Officer visit Shanghai Biotecan, which was the first partner of the international clinical trial base.This visit and negotiation further promote the clinical trials of the preliminary study of the progress of cooperation projects, optimize the research program, and more deep the cooperation of Biotecan and Germany Phenex Pharmaceuticals AG.
January 4, 2010, Under the leadership of Zhangjiang Biomedical Base Development Co., Ltd. The leaders of Zhangjiang listened the introduction of the company's operating status from Lou JingWei, the Chairman of the board of directors of Shanghai Biotecan, the report of the performance of the year and the concrete plan for the rapid development of Biotecan in 2010. After listening to the report, president Liu give a high degree of evaluation.
On September 29th, 2009, Shanghai Biotecan Pharmaceuticals Co., Ltd signed a cooperation agreement with Guangdong Yibao Pharmaceuticals Co., Ltd and started a cooperative project on molecular diagnostics in Guangdong Province.
First Shanghai Centre, 180 Zhangheng Rd., Pudong New District, Shanghai, China